ERGIC2 antibody - N-terminal region
Produktgrößen
25ul
£177,00
ARP39265-T100-25UL
100 ul
£373,00
ARP39265-T100-100UL
Über dieses Produkt
- SKU:
- ARP39265-T100
- Zusätzliche Namen:
- PTX1; CDA14; Erv41; cd002
- Klonalität:
- Polyclonal
- Konzentration:
- 1.0 mg/ml
- Weitere Details:
- ERGIon Channel2 possibly play role in transport between endoplasmic reticulum and Golgi. ERGIon Channel2 is downregulated in prostate cancer. ERGIon Channel2 may play an important role in the growth and tumorigenicity of PC-3 prostate tumor cells. Ectopic expression of a partial sequence of ERGIon Channel2 as a VP22-fusion protein in prostate cancer cell line; PC-3; induced cellular senescence. Interferon-beta (IFN-beta) and a number of IFN-inducible genes were upregulated by the ERGIon Channel2-VP22 fusion protein.
- Gendetails:
- ERGIC and golgi 2
- Host:
- Rabbit
- Immunogen:
- The immunogen is a synthetic peptide directed towards the N terminal region of human ERGIC2
- Molekulargewicht:
- 43kDa
- Proteindetails:
- Endoplasmic reticulum-Golgi intermediate compartment protein 2
- Aufreinigung:
- Protein A purified
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- For short term use; store at 2-8C up to 1 week. For long term storage; store at -20C in small aliquots to prevent freeze-thaw cycles.
- Hersteller:
- Aviva Systems Biology
- Typ:
- Antibodies: Polyclonal Antibody
- Datenblatt des Herstellers:html_datasheet.php